Bernard Prendergast

Showing 1-20 of 25 articles

Interventions for valvular disease

Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

February 7, 2020 | 10.4244/EIJ-D-19-00797

2019 – A leap year for valvular heart disease

Tamburino C, Piazza N, Baumbach A, Windecker S, Maisano F, Prendergast B

November 15, 2019 | 10.4244/EIJV15I10A154

Residual challenges in TAVI: moving forward

Barbanti M, Webb J, Dvir D, Prendergast B

November 15, 2019 | 10.4244/EIJ-D-19-00788

Interventions for valvular disease

A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane.

Iannopollo G, Romano V, Buzzatti N, De Backer O, Søndergaard L, Merkely B, Prendergast B, Giannini F, Colombo A, Latib A, Granada J, Chieffo A, Montorfano M

October 29, 2019 | 10.4244/EIJ-D-19-00951

Mitral valve regurgitation: a plea for transcatheter mitral valve replacement

Modine T, Prendergast B, Piazza N, Overtchouk P

September 20, 2019 | 10.4244/EIJV15I7A103

Interventions for valvular disease

The evolution of device technology in transcatheter aortic valve implantation

Bourantas C, Modolo R, Baumbach A, Søndergaard L, Prendergast B, Ozkor M, Kennon S, Mathur A, Mullen M, Serruys P

April 5, 2019 | 10.4244/EIJ-D-18-01048

PCI in TAVI patients: who, why and when?

Patterson T, Prendergast B, Redwood S

December 7, 2018 | 10.4244/EIJV14I11A209

Optimal structure of TAVI heart centres in 2018

Nerla R, Prendergast B, Castriota F

September 7, 2018 | 10.4244/EIJ-D-18-00656

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?

Dawkins S, Modine T, Windecker S, Piazza N, Prendergast B

November 20, 2017 | 10.4244/EIJV13I10A178

Transcatheter aortic valve implantation – practice makes perfect

Dawkins S, Prendergast B

October 20, 2017 | 10.4244/EIJV13I8A132

Interventions for valvular disease

Welcome to PCR London Valves 2017

Tamburino C, Haude M, Windecker S, Piazza N, Prendergast B

September 24, 2017 | 10.4244/EIJV13SAAA1

Interventions for valvular disease

The big parade: emerging percutaneous mitral and tricuspid valve devices

Natarajan D, Joseph J, Denti P, Redwood S, Prendergast B

September 24, 2017 | 10.4244/EIJ-D-17-00571

Coronary interventions

A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)

De Maria G, Fahrni G, Alkhalil M, Cuculi F, Dawkins S, Wolfrum M, Choudhury R, Forfar J, Prendergast B, Yetgin T, van Geuns R, Tebaldi M, Channon KM, Kharbanda R, Rothwell P, Valgimigli M, Banning A

November 20, 2016 | 10.4244/EIJV12I10A202

Interventions for valvular disease

Durability of transcatheter heart valves – much ado about nothing

Prendergast B, Tamburino C, Piazza N, Haude M, Windecker S

September 18, 2016 | 10.4244/EIJV12I7A134

Interventions for valvular disease

Welcome to PCR London Valves 2016: back to the UK

Tamburino C, Windecker S, Piazza N, Haude M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA1

Interventions for valvular disease

Intrepid transcatheter mitral valve replacement system: technical and product description

Meredith I, Bapat V, Morriss J, McLean M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA21

Interventions for valvular disease

Percutaneous interventional options for the treatment of tricuspid regurgitation

Haude M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA28

Interventions for valvular disease

Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial – transcatheter or surgical aortic-valve replacement in intermediate-risk patients

Natarajan D, Makkar R, Maccarthy P, Eltchaninoff H, Søndergaard L, Prendergast B

August 20, 2016 | 10.4244/EIJV12I6A131

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

1
2

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke